Overview

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

Status:
Completed

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl for the potential treatment of breakthrough pain episodes in patients who have chronic noncancer pain.

Phase:

Phase 3

Details

Lead Sponsor:

Cephalon

Treatments:

Fentanyl